Zika virus (ZIKV) is unique among human-pathogenic flaviviruses by its association with
congenital anomalies and trans-placental and sexual human-to-human transmission …

Zika virus (ZIKV) is an emerging healthcare threat. The presence of the mosquito Aedes
species across South and Central America in combination with complementary climates …

Although Zika virus (ZIKV) was isolated approximately 70 years ago, few experimental
studies had been published prior to 2016. The recent spread of ZIKV to countries in the …

The recent emergence of Zika virus (ZIKV) in the Americas coincident with increased
caseloads of microcephalic infants and Guillain-Barre syndrome has prompted a flurry of …

The emergence of Zika virus (ZIKV) infection has stimulated several research groups to
study and collaborate to understand virus biology and pathogenesis. These efforts may …

Zika virus (ZIKV) is a mosquito-borne Flavivirus discovered in Uganda in the 1940s. To date,
three major ZIKV outbreaks have been reported. ZIKV infections have known to be primarily …

To investigate the clinical and molecular characteristics and evolution of the Zika virus
(ZIKV) in Thailand from March 2020 to March 2023. In all, 751 serum samples from …

Animal models are critical to understand disease and to develop countermeasures for the
ongoing epidemics of Zika virus (ZIKV). Here we report a non-human primate model using a …

Zika virus (ZIKV) was first discovered in 1947 in Uganda. ZIKV did not entice much attention
until Brazil hosted the 2016 Summer Olympics Game, where ZIKV attracted a global …

Animal models of Zika virus (ZIKV) are needed to better understand tropism and
pathogenesis and to test candidate vaccines and therapies to curtail the pandemic. Humans …